Biotronik's Disappearing Act
Executive Summary
Any concerns about coronary stents and their safety have, obviously, long been put to rest. But one concern still lingers in the minds of some: why use a permanent device to do a temporary job? Phrased differently, how much better would it be to have a stent that, upon completing the remodeling job to keep the arteries open, simply disappeared? That's the promise of bioabsorbable stents. And one company, Berlin-based Biotronik GMBH & Co., hopes to capitalize on that promise.
You may also be interested in...
ART: Bucking the Trend in Bioabsorbable Stents
Bioabsorbable stents arouse great enthusiasm among both interventionalists and industry executives, because they have one major advantage over current stents, both bare metal and drug-eluting: they obviate the need for a permanent implant when only a temporary scaffolding effect is needed. Many stent companies are hedging their bets, working on stents that incorporate both drug elution and bioabsorbability--but not Paris-based Arterial Remodeling Technologies, which is arguing that natural healing, not drug therapy, is the best approach to therapeutically active stents.
ART: Bucking the Trend in Bioabsorbable Stents
Bioabsorbable stents arouse great enthusiasm among both interventionalists and industry executives, because they have one major advantage over current stents, both bare metal and drug-eluting: they obviate the need for a permanent implant when only a temporary scaffolding effect is needed. Many stent companies are hedging their bets, working on stents that incorporate both drug elution and bioabsorbability--but not Paris-based Arterial Remodeling Technologies, which is arguing that natural healing, not drug therapy, is the best approach to therapeutically active stents.
Millimed's Play in Interventional Neurology
Ten years ago, a group of executives launched Jomed with the thought of challenging the large cardiovascular device companies as a global player. Jomed never quite achieved that goal--though it came close. Now, with an innovative NO-loaded balloon, some former Jomed executives hope to do in interventional neurology what they tried to do in interventional cardiology.